|
Status |
Public on Mar 06, 2024 |
Title |
MY-COMP, an inhibitor of the transcriptional activity of YAP-B-MYB, identifies NEK2 as a novel mediator of YAP oncogenesis in uveal melanoma cells |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
38182898 |
Submission date |
Mar 22, 2023 |
Last update date |
Mar 07, 2024 |
Contact name |
Carsten P Ade |
Organization name |
University of Wuerzburg
|
Department |
Lehrstuhl Biochemie und Molekularbiologie
|
Lab |
AG Martin Eilers
|
Street address |
Am Hubland
|
City |
Wuerzburg |
ZIP/Postal code |
97074 |
Country |
Germany |
|
|
Platforms (2) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
GPL30173 |
NextSeq 2000 (Homo sapiens) |
|
Samples (29)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE227972 |
MY-COMP, an inhibitor of the transcriptional activity of YAP-B-MYB, identifies NEK2 as a novel mediator of YAP oncogenesis in uveal melanoma cells [CUT&RUN] |
GSE227973 |
MY-COMP, an inhibitor of the transcriptional activity of YAP-B-MYB, identifies NEK2 as a novel mediator of YAP oncogenesis in uveal melanoma cells [RNA-seq] |
|
Relations |
BioProject |
PRJNA947598 |